Common Contracts
2 similar null contracts by MiNK Therapeutics, Inc.
MiNK THERAPEUTICS, INC. Convertible Promissory Note UP TO $5,000,000 February 12, 2024MiNK Therapeutics, Inc. • March 21st, 2024 • Biological products, (no disgnostic substances) • Delaware
This Convertible Promissory Note (this “Note”) is being issued by the Company pursuant to that certain Convertible Promissory Note Purchase Agreement, dated as of the date hereof, by and among the Company and the Holder (the “Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Purchase Agreement.
AGENTUS THERAPEUTICS, INC. Convertible Promissory NoteMiNK Therapeutics, Inc. • September 14th, 2021 • Biological products, (no disgnostic substances) • Delaware
This Convertible Promissory Note (this “Note”) is being issued by the Company pursuant to that certain Convertible Promissory Note Purchase Agreement, dated as of the date hereof, by and among the Company and the Holder (the “Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Purchase Agreement.
